122 related articles for article (PubMed ID: 37429790)
21. LncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer.
Yan H; Li H; Silva MA; Guan Y; Yang L; Zhu L; Zhang Z; Li G; Ren C
J Exp Clin Cancer Res; 2019 Aug; 38(1):356. PubMed ID: 31412903
[TBL] [Abstract][Full Text] [Related]
22. Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis.
Kang W; Tong JH; Chan AW; Lee TL; Lung RW; Leung PP; So KK; Wu K; Fan D; Yu J; Sung JJ; To KF
Clin Cancer Res; 2011 Apr; 17(8):2130-9. PubMed ID: 21346147
[TBL] [Abstract][Full Text] [Related]
23. Abnormal activation of RFC3, A YAP1/TEAD downstream target, promotes gastric cancer progression.
Guo Z; Guo L
Int J Clin Oncol; 2024 Apr; 29(4):442-455. PubMed ID: 38383698
[TBL] [Abstract][Full Text] [Related]
24. Androgen receptor promotes cell stemness via interacting with co-factor YAP1 in gastric cancer.
Hou J; Pan T; Li F; Sang Q; Wu X; Li J; Yu B; Zang M; Zhu ZG; Su L; Liu B
Biochem Pharmacol; 2023 Nov; 217():115849. PubMed ID: 37806457
[TBL] [Abstract][Full Text] [Related]
25. The interaction of TEA domain transcription factor 4 (TEAD4) and Yes-associated protein 1 (YAP1) promoted the malignant process mediated by serum/glucocorticoid regulated kinase 1 (SGK1).
He S; Zhang H; Xiao Z; Bhushan S; Gao K; Wang W
Bioengineered; 2021 Dec; 12(1):601-614. PubMed ID: 33517828
[TBL] [Abstract][Full Text] [Related]
26. Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells.
Giraud J; Molina-Castro S; Seeneevassen L; Sifré E; Izotte J; Tiffon C; Staedel C; Boeuf H; Fernandez S; Barthelemy P; Megraud F; Lehours P; Dubus P; Varon C
Int J Cancer; 2020 Apr; 146(8):2255-2267. PubMed ID: 31489619
[TBL] [Abstract][Full Text] [Related]
27. MiR-92 overexpression suppresses immune cell function in ovarian cancer via LATS2/YAP1/PD-L1 pathway.
Feng S; Sun H; Zhu W
Clin Transl Oncol; 2021 Mar; 23(3):450-458. PubMed ID: 32654106
[TBL] [Abstract][Full Text] [Related]
28. RP11-323N12.5 promotes the malignancy and immunosuppression of human gastric cancer by increasing YAP1 transcription.
Wang J; Huang F; Shi Y; Zhang Q; Xu S; Yao Y; Jiang R
Gastric Cancer; 2021 Jan; 24(1):85-102. PubMed ID: 32623586
[TBL] [Abstract][Full Text] [Related]
29. [Doublecortin-like kinase 1 activates Hippo pathway to promote migration, invasion and proliferation of pancreatic cancer cells].
Yan R; Liang ZW; Liu HS; Ge Y; An GY
Zhonghua Zhong Liu Za Zhi; 2023 Jul; 45(7):594-604. PubMed ID: 37462016
[No Abstract] [Full Text] [Related]
30. Up-regulated acylglycerol kinase (AGK) expression associates with gastric cancer progression through the formation of a novel YAP1-AGK-positive loop.
Huang S; Cao Y; Guo H; Yao Y; Li L; Chen J; Li J; Xiang X; Deng J; Xiong J
J Cell Mol Med; 2020 Oct; 24(19):11133-11145. PubMed ID: 32827244
[TBL] [Abstract][Full Text] [Related]
31. LINC00662 promotes gastric cancer cell growth by modulating the Hippo-YAP1 pathway.
Liu Z; Yao Y; Huang S; Li L; Jiang B; Guo H; Lei W; Xiong J; Deng J
Biochem Biophys Res Commun; 2018 Nov; 505(3):843-849. PubMed ID: 30297104
[TBL] [Abstract][Full Text] [Related]
32. Physical and functional interaction between hepatitis C virus NS5A protein and ovarian tumor protein deubiquitinase 7B.
Sianipar IR; Matsui C; Minami N; Gan X; Deng L; Hotta H; Shoji I
Microbiol Immunol; 2015 Aug; 59(8):466-76. PubMed ID: 26112491
[TBL] [Abstract][Full Text] [Related]
33. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
[No Abstract] [Full Text] [Related]
34. OTUD7B stabilizes estrogen receptor α and promotes breast cancer cell proliferation.
Tang J; Wu Z; Tian Z; Chen W; Wu G
Cell Death Dis; 2021 May; 12(6):534. PubMed ID: 34035221
[TBL] [Abstract][Full Text] [Related]
35. Integrative genomics analysis reveals the multilevel dysregulation and oncogenic characteristics of TEAD4 in gastric cancer.
Lim B; Park JL; Kim HJ; Park YK; Kim JH; Sohn HA; Noh SM; Song KS; Kim WH; Kim YS; Kim SY
Carcinogenesis; 2014 May; 35(5):1020-7. PubMed ID: 24325916
[TBL] [Abstract][Full Text] [Related]
36. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.
Pan Y; Tong JHM; Lung RWM; Kang W; Kwan JSH; Chak WP; Tin KY; Chung LY; Wu F; Ng SSM; Mak TWC; Yu J; Lo KW; Chan AWH; To KF
Mol Cancer; 2018 Jul; 17(1):102. PubMed ID: 30037330
[TBL] [Abstract][Full Text] [Related]
37. YAP1-induced MALAT1 promotes epithelial-mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer.
Sun Z; Ou C; Liu J; Chen C; Zhou Q; Yang S; Li G; Wang G; Song J; Li Z; Zhang Z; Yuan W; Li X
Oncogene; 2019 Apr; 38(14):2627-2644. PubMed ID: 30531836
[TBL] [Abstract][Full Text] [Related]
38. Interaction of YAP1 and mTOR promotes bladder cancer progression.
Xu M; Gu M; Zhou J; Da J; Wang Z
Int J Oncol; 2020 Jan; 56(1):232-242. PubMed ID: 31789387
[TBL] [Abstract][Full Text] [Related]
39. NUAK2 silencing inhibits the proliferation, migration and epithelial‑to‑mesenchymal transition of cervical cancer cells via upregulating CYFIP2.
Li Y; Song X; Liu L; Yue L
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34558636
[TBL] [Abstract][Full Text] [Related]
40. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
